Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director, 10%+ Owner | $206M | -$19.2M | -8.54% | Nov 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|